Featured Article
From Bench to Bedside and Back
Interaction between scientists and clinicians.
ICR and Horizon Discovery to Collaborate on Genome-wide Synthetic-lethality Screens
27 Aug 2010
The ICR and Horizon Discovery (Horizon) are forming a collaboration aimed at rapidly screening the human genome for novel drug targets that selectively kill cancer cells.
Herpes Virus Treats Head and Neck Cancer Patients
30 Jul 2010
A genetically engineered cold sore virus has been used to treat head and neck cancer patients in a Phase I/II clinical trial.
ICR Chief Executive to Become Deputy Chairman of the Wellcome Trust
23 Jul 2010
He will take up the position at the independent, global biomedical charity in October.
Therapy Reduces Dangerous Side-effects
20 Jul 2010
Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect.
